Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,266.19
-11.32(-0.21%)
Dow
38,474.79
-211.53(-0.55%)
Nasdaq
16,755.27
+20.26(+0.12%)
Bitcoin USD
68,895.64
+740.56(+1.09%)
CMC Crypto 200
1,484.24
+16.30(+1.11%)

BMY Jan 2025 28.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.3300

0.0000

(0.00%)

As of 02:35PM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....